Home Page
 
Skip navigation links
Home
About Us
Business Assistance
Funding
News & Events
Facts & Maps
Resources
Skip Navigation LinksMaryland Biotechnology Center > News Events

News Archive 

Maryland Academic News: 2009 

December

"Mini" Stem Cell Transplant May Reverse Severe Sickle Cell Disease, National Institutes of Health (NIH) And Johns Hopkins University Study
Los Angeles Times
Researchers have for the first time performed a successful bone marrow transplant to cure sickle cell disease in adults, a feat that could expand the procedure to more of the 70,000 Americans with the disease -- and possibly some other diseases as well.  Read More...

November

Niacin Adds No Benefit for Statin Patients, Johns Hopkins University School of Medicine Study
Health Day
The addition of niacin to statin therapy in secondary-prevention patients resulted in a significant improvement in LDL- and HDL-cholesterol levels but failed to significantly alter atherosclerotic disease progression as measured by MRI, compared with statin therapy alone. Read More...

Niacin Bests Ezetimibe as Add-On Therapy, Johns Hopkins University School of Medicine Researchers Say
MedPageToday
Boosting HDL cholesterol with extended-release niacin (Niaspan) is a more effective way of slowing atherosclerosis in high-risk patients on long-term statin therapy than seeking additional LDL cholesterol reductions by adding ezetimibe (Zetia), researchers here reported.
Read More...

Drug Slows Tumor Growth: Gonorrhea Medication Might Help Fight Cancer, Johns Hopkins University Study
ScienceDaily
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. The newest surprise discovered by researchers at the Johns Hopkins University School of Medicine is a gonorrhea medication that might help battle cancer. Read More...

New Activity Found For A Potential Anti-cancer Agent From Marine Sponges, Texas A&M University and Johns Hopkins University Study
ScienceDaily
Pateamine A (PatA), a natural product first isolated from marine sponges, has attracted considerable attention as a potential anti-cancer agent, and now a new activity has been found for it, which may reveal yet another anti-cancer mechanism. That's the assessment of Daniel Romo, a Texas A&M chemistry professor, and his colleagues at Johns Hopkins University who are pioneers in research involving this novel marine natural product. Read More...

Industry support of academic life science research may be dropping
Genetic Engineering & Biotechnology News
While more than half the academic life science researchers responding to a 2007 survey indicated having some relationship with industrial entities, the prevalence of such relationships particularly direct funding for research studies appears to be dropping. Read More...

October

USC, Johns Hopkins Win $10.4M from NCI
GenomeWeb
The University of Southern California and Johns Hopkins University have been awarded $10.4 million from the National Cancer Institute for cancer epigenomics research that will contribute data to NCI's Cancer Genome Atlas program.
Read More...

'Moonlighting' Molecules Discovered; Johns Hopkins University School of Medicine Researchers Uncover New Kink In Gene Control
ScienceDaily
A collaborative effort at the Johns Hopkins School of Medicine to examine protein-DNA interactions across the whole genome has uncovered more than 300 proteins that appear to control genes, a newly discovered function for all of these proteins previously known to play other roles in cells. Read More...

UM-Baltimore Wins $12.2M for Chlamydia Studies
GenomeWeb
The National Institutes of Allergy and Infectious Diseases has granted $12.2 million to the University of Maryland, Baltimore, to conduct genomic analysis of the bacteria that causes Chlamydia and how it interacts within the human body. Read More...

University of Maryland Institute of Human Virology wins $18M in grants
Washington Business Journal
The University of Maryland’s Institute of Human Virology has won 10 new federal grants worth $18 million that researchers will use to develop medical therapies to treat AIDS around the world. Read More...

NWU, UMB to Share $1M ARRA Grant for Disease Ontology
GenomeWeb
Northwestern University and the University of Maryland, Baltimore, will share a two-year, $1 million American Reinvestment and Recovery Act grant from the National Institutes of Health to develop a computable disease ontology, the schools said today. Read More...

Hopkins scientist shares Nobel Prize
The Baltimore Sun
Carol W. Greider, who on Monday became the 33rd person associated with the Johns Hopkins University  to win the  Nobel Prize, is a triathlete, a mother of two and a methodical and modest genetic researcher who colleagues say shuns publicity in favor of pursuing her passion: fundamental, curiosity-driven science. 
Read More....

Americans Elizabeth Blackburn, Carol Greider and Jack Szostak win Nobel medicine prize
Chicago Tribune
Americans Elizabeth H. Blackburn, Carol W. Greider and Jack W. Szostak won the 2009 Nobel Prize in medicine on Monday for discovering a key mechanism in the genetic operations of cells, an insight that has inspired new lines of research into cancer
Read More....

September

Salisbury University starts work on new $56M Perdue School of Business building
Baltimore Business Journal
Salisbury University is breaking ground Tuesday on a new $56 million home for its Perdue School of Business. Read More....

Genentech, Inc. (DNA)'s Hedgehog Drug Helps Late-Stage Cancers, Johns Hopkins University, Karmanos Cancer Institute And Translational Genomics Research Institute (TGen) Study
Reuters
An experimental cancer pill made by Roche's Genentech shrank tumors in patients whose skin cancer had spread, raising hope for a new class of drugs that may have an affect on many other cancers as well, U.S. researchers said on Wednesday. Read More...

August

Gene Variation Strongly Predicts Plavix Response, University of Maryland Study 
Reuters
A common gene variation explains why many people are not helped by the widely prescribed blood thinner Plavix, U.S. researchers said on Tuesday in a study confirming earlier research and paving the way for tests to screen patients before they get the drug. Read More...

Team Uses GWAS to ID Biomarker for Hepatitis C Treatment Response
GenomeWeb
Scientists from Duke University, the Schering-Plough Research Institute, and Johns Hopkins University have identified a genetic marker that may help predict treatment response in individuals infected with one of the most common hepatitis C virus strains. Read More...

Sleep Apnea Raises Death Risk 46 Percent, Johns Hopkins University Study
Reuters
Severe sleep apnea raises the risk of dying early by 46 percent, U.S. researchers reported on Monday, but said people with milder sleep-breathing problems do not share that risk. Read More...

Johns Hopkins Hospital named among most beautiful
Baltimore Business Journal
Johns Hopkins Hospital has been named among the 20 most beautiful hospitals in the nation for 2009. Read More...

Hagerstown Community College receives NSF Grant
Press Release
Officials at Hagerstown Community College announced today that the college has been awarded a $672,696 grant from the National Science Foundation. Read More...

Is there long-term brain damage after bypass surgery? More evidence puts the blame on heart disease
EurekAlert!
Brain scientists and cardiac surgeons at Johns Hopkins have evidence from 227 heart bypass surgery patients that long-term memory losses and cognitive problems they experience are due to the underlying coronary artery disease itself and not ill after-effects from having used a heart-lung machine.
Read More...

Hepatitis C Infection: Treatment Options Equally Effective, Likelihood Of Success Known Early On
Science Daily
Results of a long-awaited study of 3,070 American adults at Johns Hopkins and 118 other U.S. medical centers show that treatment with either of the two standard antiviral drug therapies is safe and offers the best way for people infected with hepatitis C to prevent liver scarring, organ failure and death. Read More...

 back to top

July

Prototype, 7-foot-tall sanitizer automates disinfection of hard-to-clean hospital equipment
Press Release
Hopkins experts in applied physics, computer engineering, infectious diseases, emergency medicine, microbiology, pathology and surgery have unveiled a 7-foot-tall, $10,000 shower-cubicle-shaped device that automatically sanitizes in 30 minutes.
Read More...

Daily Potassium Citrate Wards Off Kidney Stones In Seizure Patients On High-fat Diet
Science Daily
Children on the high-fat ketogenic diet to control epileptic seizures can prevent the excruciatingly painful kidney stones that the diet can sometimes cause if they take a daily supplement of potassium citrate the day they start the diet, according to research from Johns Hopkins Children's Center.
Read More...

Johns Hopkins Hopes to Develop 600 Acres In Montgomery County Into Life-Sci Campuses
GenomeWeb News
Maryland’s Montgomery County could see its life-science footprint grow more than 1,000 acres over the next decade as two Johns Hopkins University projects enter the planning stages, while the county itself eyes a third project.
Read More...

U.S. trials for H1N1 vaccine announced
CNN News
In a race to beat the flu season, medical institutes across the United States will begin human trials for a new H1N1 flu vaccine starting in early August.
Read More... 

Experts analyze parasites to find "snail fever" drugs
Reuters
Scientists at the University of Maryland have mapped out the genomes of two parasites that cause snail fever, a disease that afflicts 210 million rural people worldwide and for which there is still no vaccine.
Read More...

Students Embed Stem Cells In Sutures To Enhance Healing
Science Daily
Johns Hopkins biomedical engineering students have demonstrated a practical way to embed a patient's own adult stem cells in the surgical thread that doctors use to repair serious orthopedic injuries such as ruptured tendons.
Read More...

New UMBI research collaborative could attract more federal funds
Baltimore Business Journal
Leading stem cell and genomics researchers from the University of Maryland, Baltimore may move into downtown Baltimore’s Columbus Center next year to collaborate with researchers at the University of Maryland Biotechnology Institute.
Read More...

 back to top

  social media links
 

Molecule

Contact the Office | Site Map | Accessibility | Privacy Note | Refund Policy | Terms Of Use   
9700 Great Seneca Highway, Rockville, MD 20850 301-762-9214   
401 East Pratt Street, 7th Floor, Baltimore, MD 21202 410-767-0505